DeepSummary
The transcript is a recording of a live podcast taping at South by Southwest (SXSW) discussing the role AI is playing in reshaping the landscape of cancer care. The panel featured experts from the healthcare industry, including Maima Carmo, founder of the Tigerlily Foundation, Ed Cox, head of digital health and medicines at Pfizer, and Julie Gerberding, CEO of the Foundation for the National Institutes of Health.
The panelists explored how AI can help make cancer care more personalized, equitable, and effective. They discussed the potential of AI in areas like early detection, personalized treatment, and understanding the biological mechanisms driving cancer. The conversation also touched on the importance of including diverse patient perspectives in developing AI solutions and ensuring access to these technologies.
Looking ahead, the panelists shared their visions for the future of cancer care with AI. They expressed hope that AI could help turn cancer into a curable condition through precision diagnosis and treatment. Additionally, they envisioned redirecting resources towards improving quality of life and addressing social determinants of health once cancer becomes more manageable.
Key Episodes Takeaways
- AI has the potential to transform cancer care by enabling more personalized, equitable, and effective treatment.
- Including diverse patient perspectives and addressing social determinants of health is crucial in developing AI solutions for cancer care.
- AI could help turn cancer into a curable condition through precision diagnosis and treatment.
- AI-enabled solutions should prioritize empathy and support for patients, alongside providing information and resources.
- Collaboration across academia, government, and industry is essential for leveraging AI to advance cancer research and care.
- AI can help streamline processes, support healthcare workers, and improve accessibility to high-quality care globally.
- The ultimate goal of AI in cancer care is to improve patient outcomes, prolong lives, and enhance quality of life.
- Reallocating resources towards improving wellbeing and addressing social determinants of health could become a greater priority as cancer becomes more manageable with AI.
Top Episodes Quotes
- βYou know, when someone's concussed, usually information isn't what they need. What they need is empathy. They need that, you know, that coming together. And what's nice about an AI solution in that context is later, when they've had a chance to process, they won't remember anything that got said except the one big thing that they were told, but they can go back and find, hopefully, a patient friendly resource that will help them get the information they need. I think as a society that just coming out of a terrible phase of a pandemic, we're craving empathy.β by Julie Gerberding
- βI think if we're talking about ten years from now, you're talking about digital health is ubiquitous in every corner of the world, right? Anywhere there's connectivity, anywhere there's a smartphone, people are getting world class health because they have connectivity and they have a smartphone.β by Ed Cox
Entities
Concept
Company
Organization
Person
Product
Event
Podcast
Disease
Episode Information
Impact Theory with Tom Bilyeu
Impact Theory
6/25/24
Introducing Live from SXSW - The Future of Cancer from Science Will Win.
Follow the show: Science Will Win
In a live taping of the Science Will Win podcast, Host and Artificial Intelligence Expert Jeremiah Owyang speaks to cutting-edge healthcare leaders about the impact that AI is having on the future of cancer. Thirty years ago, the thought of a world without cancer was nothing more than a dream. Similarly, AI was considered a technology that had yet to become reality. Today, we are reimagining a future where the AI revolution will help change the trajectory of cancer as we know it.
Featured experts:
- Edward Cox, Head & General Manager Of Digital Health & Medicines, Pfizer
- Julie Gerberding, CEO and President, Foundation for the National Institutes of Health
- Maimah Karmo, Founder & CEO, Tigerlily Foundation
This episode was recorded live in Austin, TX on Monday March 11 as part of Pfizerβs takeover of the South by Southwest podcasting lounge.Β
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to team@podroll.fm.